ClinicalTrials.gg
RecruitingNCT07838051Updated Sep 24, 2026

Effect of Muscle Relaxants on Postoperative Sore Throat in Video Laryngeal Mask Airway(LMA) Use

An observational study in Laryngeal Mask Airway, sponsored by Samsun University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-09-24.

Primary conditionPharyngitis(the registry's first term)UnverifiedIs this wrong?The registry often attaches Pharyngitis to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Samsun University · Observational

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
90
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Video laryngeal masks (VLMAs) are increasingly used as a minimally invasive alternative in airway management. The use of neuromuscular blocking agents can affect VLMA placement and airway physiology. As a result, there may be differences in postoperative respiratory complications and middle ear pressure.

Read the detailed description

Video laryngeal masks (VLMAs) are frequently used in airway management. Especially in surgical procedures lasting longer than one hour, VLMA cuff pressure, positive pressure ventilation, and airway manipulations are associated with postoperative sore throat and changes in middle ear pressure. The aim of this study is to evaluate the effect of neuromuscular blocker (rocuronium) administration on postoperative sore throat during video laryngeal mask use in surgical procedures lasting longer than one hour. Furthermore, it aims to examine its effects on changes in middle ear pressure, oropharyngeal leak pressure, and airway-related clinical parameters.

02

Conditions studied

  • Laryngeal Mask Airway

Browse trials for

Keywords

  • laryngeal mask airway
  • middle ear pressure
  • sore throat
03

In context

Pharyngitis Unverified

226 studies on the registry are indexed under Pharyngitis; 35 are open to participants now.

This study's planned enrollment of 90 is below the median of 289 across 33 observational studies indexed under Pharyngitis.

Browse Pharyngitis studies →

Lead sponsor

Samsun University is the lead sponsor of 89 studies on the registry; 20 are open to participants now.

Compared within Pharyngitis, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Participants who will use a laryngeal mask in their surgical procedures

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Cases lasting longer than 1 hour
  • Participants with >30
  • Participants with , II, III

Exclusion criteria

Exclusion Criteria:

  • Participants with a \< 30
  • Pregnant women
  • Participants with expected difficult airway passage
  • Cases lasting less than 1 hour
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
90 participants (estimated)
Patient registry
No

Groups and cohorts

  • Group K

    In this group, a video laryngeal mask will be implanted with the aid of a neuromuscular blocker.

    Drug: using rocuronium before vide laryngeal mask airway

  • Group S

    In this group, a video laryngeal mask will be placed without the use of neuromuscular blockers.

Interventions

06

What researchers measure

Primary outcomes

  1. Postoperative sore throat

    Postoperative sore throat will be assessed using NRS (0: no pain, 10: most severe pain).

    Time frame: 24 hours

Secondary outcomes

  1. Changes in middle ear pressure

    In this study, middle ear pressure will be assessed using tympanometry during the preoperative period, immediately after induction of anesthesia, following endotracheal intubation, and at the 3rd and 5th minutes thereafter.

    Time frame: 1 hour

  2. Oropharyngeal leak pressure

    Oropharyngeal leak pressure (OLP) was measured by closing the adjustable pressure-limiting (APL) valve with a fresh gas flow of 3 L/min, and the airway pressure at which an audible leak occurred or the manometer pressure reached a plateau was recorded as the OLP (cmH₂O).

    Time frame: during surgery

  3. video laryngeal mask airway placement time

    Video laryngeal mask airway placement time will be recorded after induction.

    Time frame: 2 minutes after induction

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Dec 2026, 7 months after the start.

Of 21 observational studies under Pharyngitis, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 29. This study's planned 7 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 1, 2026
First posted
Sep 24, 2026
StartActual
May 4, 2026
Primary completionEst.
Dec 30, 2026
CompletionEst.
Dec 31, 2026
Last update
Sep 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07838051
Lead sponsor
Samsun University
Responsible party
Sponsor
First posted
Sep 24, 2026
Start date
May 4, 2026
Primary completion
Dec 30, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Sep 24, 2026

Study contacts

Hatice Selçuk Kuşderci
Contact
drkusderci@hotmail.com
+905052159896
hatice selçuk kuşderci
principal investigator · Samsun City Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion